Call Options

7 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2021

May 17, 2021

BUY
$153.07 - $170.48 $535,745 - $596,680
3,500 Added 218.75%
5,100 $838,000
Q4 2020

Feb 16, 2021

SELL
$137.11 - $157.38 $2.36 Million - $2.71 Million
-17,200 Reduced 91.49%
1,600 $252,000
Q2 2020

Aug 14, 2020

BUY
$128.81 - $155.51 $2.37 Million - $2.86 Million
18,400 Added 4600.0%
18,800 $2.64 Million
Q1 2020

May 15, 2020

SELL
$111.14 - $153.99 $2.06 Million - $2.85 Million
-18,500 Reduced 97.88%
400 $52,000
Q4 2019

Feb 14, 2020

BUY
$127.5 - $146.44 $2.41 Million - $2.77 Million
18,900 New
18,900 $2.76 Million
Q2 2019

Aug 14, 2019

SELL
$131.15 - $144.24 $2.95 Million - $3.25 Million
-22,500 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$125.72 - $139.79 $2.83 Million - $3.15 Million
22,500 New
22,500 $3.15 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $403B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Prelude Capital Management, LLC Portfolio

Follow Prelude Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.